SEP 8, 2026 · JOURNAL ARTICLE
Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia
JAMA Network Open
A cross-sectional survey of clinical practice and implementation challenges with no quantitative comparison group, efficacy data, or primary outcome measure; descriptive in nature and identifying barriers rather than testing an intervention or confirming an effect.
Reported
Survey response rate (institution…147 of 195
NCORP participant institutions35 (23.8%)
Blinatumomab standard therapy ado…134 centers (91.2%)